AAAAAA
Results:
1-20
|
Results: 20
Authors:
DORIGO O
TURLA ST
LEBEDEVA S
GJERSET RA
Citation: O. Dorigo et al., SENSITIZATION OF RAT GLIOBLASTOMA-MULTIFORME TO CISPLATIN IN-VIVO FOLLOWING RESTORATION OF WILD-TYPE P53 FUNCTION, Journal of neurosurgery, 88(3), 1998, pp. 535-540
Authors:
FAKHRAI H
SHAWLER DL
VANBEVEREN C
LIN H
DORIGO O
SOLOMON MJ
GJERSET RA
SMITH L
BARTHOLOMEW RM
BOGGIANO CA
GOLD DP
SOBOL RE
Citation: H. Fakhrai et al., CONSTRUCTION AND CHARACTERIZATION OF RETROVIRAL VECTORS FOR INTERLEUKIN-2 GENE-THERAPY, Journal of immunotherapy, 20(6), 1997, pp. 437-448
Authors:
DORIGO O
BEREK JS
Citation: O. Dorigo et Js. Berek, GENE-THERAPY FOR OVARIAN-CANCER - DEVELOPMENT OF NOVEL TREATMENT STRATEGIES, International journal of gynecological cancer, 7(1), 1997, pp. 1-13
Authors:
SHAWLER DL
DORIGO O
VANBEVEREN C
BARTHOLOMEW RM
FAKHRAI H
SOBOL RE
Citation: Dl. Shawler et al., INTERLEUKIN-2 (IL-2) GENE-THERAPY WITH ALLOGENEIC FIBROBLASTS IN THE CT-26 MODEL OF MURINE COLORECTAL-CARCINOMA, Oncology Reports, 4(1), 1997, pp. 135-138
Authors:
GJERSET RA
DORIGO O
MAUNG V
LEBEDEVA S
Citation: Ra. Gjerset et al., TUMOR-REGRESSION IN-VIVO FOLLOWING P53 COMBINATION THERAPY, Cancer gene therapy, 4(6), 1997, pp. 2-2
Authors:
DORIGO O
YOUNG J
RIBAS A
ECONOMOU J
BEREK JS
Citation: O. Dorigo et al., EFFICIENCY OF ADENOVIRUS-MEDIATED GENE DELIVERY INTO HUMAN OVARIAN-CANCER CELLS IS SIGNIFICANTLY REDUCED IN PRESENCE OF OVARIAN-CANCER ASCITES AND IN 3-DIMENSIONAL CULTURE SYSTEMS, Cancer gene therapy, 4(6), 1997, pp. 74-74
Authors:
HORTON H
DORIGO O
HERNANDEZ P
ANDERSON D
BEREK J
PARKER S
Citation: H. Horton et al., GENE-THERAPY OF OVARIAN CSNFER VIA IL-2 PLASMID DNA AND CATIONIC LIPID, Cancer gene therapy, 4(6), 1997, pp. 149-149
Authors:
SOBOL RE
SHAWLER D
CARSON C
GARRETT M
VANBEVEREN C
MERCOLA D
SMITH L
BARTHOLOMEW R
BROSTOFF S
DORIGO O
GOLD D
CARLO D
ROYSTON I
FAHKRAI H
Citation: Re. Sobol et al., PRECLINICAL AND CLINICAL-EXPERIENCE OF INTERLEUKIN-2 (IL-2) AND TGF-BETA ANTISENSE GENE-THERAPY, Cancer gene therapy, 4(1), 1997, pp. 69-69
Authors:
FAKHRAI H
DORIGO O
FREDIEU A
SHAWLER DL
SOBOL RE
BLACK KL
Citation: H. Fakhrai et al., TRANSFORMING GROWTH FACTOR-B (TGF-B) ANTISENSE GENE-THERAPY OF GLIOBLASTOMA-MULTIFORME (GBM), The FASEB journal, 10(6), 1996, pp. 2384-2384
Authors:
FAKHRAI H
DORIGO O
SHAWLER DL
LIN H
MERCOLA D
BLACK KL
ROYSTON I
SOBOL RE
Citation: H. Fakhrai et al., ERADICATION OF ESTABLISHED INTRACRANIAL RAT GLIOMAS BY TRANSFORMING GROWTH-FACTOR-BETA ANTISENSE GENE-THERAPY, Proceedings of the National Academy of Sciences of the United Statesof America, 93(7), 1996, pp. 2909-2914
Authors:
GJERSET RA
FAKHRAI H
SHAWLER DL
TURLA S
DORIGO O
GROVERBARDWICK A
MERCOLA D
WEN SF
COLLINS H
LIN H
GARCIA MV
KRUSE CA
ROYSTON I
SOBOL RE
Citation: Ra. Gjerset et al., CHARACTERIZATION OF A NEW HUMAN GLIOBLASTOMA CELL-LINE THAT EXPRESSESMUTANT P53 AND LACKS ACTIVATION OF THE PDGF PATHWAY, In vitro cellular & developmental biology. Animal, 31(3), 1995, pp. 207-214
Authors:
SHAWLER DL
DORIGO O
GJERSET RA
ROYSTON I
SOBOL RE
FAKHRAI H
Citation: Dl. Shawler et al., COMPARISON OF GENE-THERAPY WITH INTERLEUKIN-2 GENE MODIFIED FIBROBLASTS AND TUMOR-CELLS IN THE MURINE CT-26 MODEL OF COLORECTAL-CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 17(4), 1995, pp. 201-208
Authors:
SOBOL RE
ROYSTON I
FAKHRAI H
SHAWLER DL
CARSON C
DORIGO O
GJERSET R
GOLD DP
KOZIOL J
MERCOLA D
VANBEVEREN C
WILSON D
Citation: Re. Sobol et al., INJECTION OF COLON-CARCINOMA PATIENTS WITH AUTOLOGOUS IRRADIATED TUMOR-CELLS AND FIBROBLASTS GENETICALLY-MODIFIED TO SECRETE INTERLEUKIN-2 (IL-2) - A PHASE-I STUDY, Human gene therapy, 6(2), 1995, pp. 195-204
Authors:
SOBOL RE
FAKHRAI H
SHAWLER D
GJERSET R
DORIGO O
CARSON C
KHALEGHI T
KOZIOL J
SHIFTAN TA
ROYSTON I
Citation: Re. Sobol et al., INTERLEUKIN-2 GENE-THERAPY IN A PATIENT WITH GLIOBLASTOMA, Gene therapy, 2(2), 1995, pp. 164-167
Authors:
SOBOL RE
DORIGO O
SHAWLER DL
LIN H
ROYSTON I
FAKHRAI H
Citation: Re. Sobol et al., IMMUNO-GENE THERAPY OF RAT GLIOMA WITH TGF-BETA-2 ANTISENSE AND IL-2 GENE MODIFIED TUMOR-CELLS, European journal of cancer, 31A, 1995, pp. 31-31
Authors:
DORIGO O
MEIER W
SCHEIDEL P
HEPP H
Citation: O. Dorigo et al., VALUE OF BOWEL RESECTION AND PREOPERATIVE COLOSCOPY IN OVARIAN-CANCER, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 966-968
Authors:
ROMISCH M
BAUER F
DAPONTE A
MEIER W
DORIGO O
EIERMANN W
Citation: M. Romisch et al., LYMPHOCYTE SUBPOPULATIONS IN WOMEN WITH M ALIGNANT-TUMORS IN CORRELATION WITH KNOWN PROGNOSTIC FACTORS AND AS DISEASE PARAMETERS DURING CYTOKINE THERAPY, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 1091-1093
Authors:
MULLER S
COLLINS H
BRAMS P
WANG H
DORIGO O
MCGRATH M
GRANT M
ROSENTHAL K
KOHLER H
Citation: S. Muller et al., A MONOCLONAL-ANTIBODY (IF7) SPECIFIC FOR HUMAN ANTI-HIV IG INDUCES APOPTOSIS AND INHIBITS CTL ACTIVITY IN CD8-1 INFECTED INDIVIDUALS( LYMPHOCYTES FROM HIV), Journal of cellular biochemistry, 1993, pp. 68-68
Authors:
HERNDIER B
MCGRATH M
ABBEY N
WANG HT
NG V
DORIGO O
KAPLAN L
MULLER S
KOHLER H
Citation: B. Herndier et al., A NON-LYMPHOMA IDIOTYPE IS INDICATIVE AND PREDICTIVE FOR B-CELL MALIGNANCIES IN AIDS, Hybridoma, 12(5), 1993, pp. 529-537
Authors:
TILLMANNS H
NEUMANN FJ
TIEFENBACHER C
DORIGO O
PAREKH N
WAAS W
ZIMMERMANN R
STEINHAUSEN M
KUEBLER W
Citation: H. Tillmanns et al., ACTIVATION OF NEUTROPHILS IN THE MICROVASCULATURE OF THE ISCHEMIC ANDREPERFUSED MYOCARDIUM, European heart journal, 14, 1993, pp. 82-86
Risultati:
1-20
|